We believe the current valuation of Apollo Hospitals Enterprises to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement, brokerage house Nomura said in its note to clients
Shares of Apollo Hospitals continued their slide Wednesday, shedding nearly 3 percent to Rs 948.50 after the company’s fourth quarter earnings announced on Monday fell short of market expectations.
Brokerage house Nomura downgraded the stock to neutral and also cut its revenue and net profit estimates for FY15 by 4-16 percent.
"Slippage in earnings, slower-than estimated growth in ARPOB (average revenue per occupied bed) and some delay in execution contribute to a 1416% cut in our earnings estimates," said the Nomura note to clients.
"We believe the current valuation to an extent captures the prospects of longer term growth and ROIC (return on invested capital) improvement. We remain constructive the over long term, but await a better entry point," the note added.
Nomura has a price target of Rs 933 for the stock, and does not see the weak fourth quarter numbers as a cause for concern.
"4Q was weak due to a bunching up of holidays and start-up costs related to two new hospitals. Expansion plans are however on track, business outlook remains strong and funding is not a concern," the Citi note to clients said.
Citi has a target price of Rs 960 for the stock.
Apollo shares had rallied nearly 40 percent in less than 2 months between March and May this year. The stock's inclusion in the MSCI India Index contributed to the positive sentiment in a major way.
"After the recent stock rally and weak operational performance, we believe the stock offers limited margin of safety," brokerage house Kotak Securities said in a note to clients.
Apollo Hospital stock price
On November 21, 2014, Apollo Hospitals Enterprises closed at Rs 1200.45, down Rs 35.85, or 2.9 percent. The 52-week high of the share was Rs 1242.75 and the 52-week low was Rs 817.00.
The company's trailing 12-month (TTM) EPS was at Rs 24.37 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 49.26. The latest book value of the company is Rs 213.10 per share. At current value, the price-to-book value of the company is 5.63.
READ MORE ON Apollo Hospital;Nomura;Citi;downgrade;target;Q4
Set email alert for
ADS BY GOOGLE